The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Centrally determined PD-L1 among non-eligible for cisplatin-based chemotherapy recurrent/metastatic head and neck patients (R/M HNSCC pts): Pathology outcomes from the NIVOTAX trial.
 
Lara Iglesias
Consulting or Advisory Role - Bayer; Lilly; Merck; Merck Sharp & Dohme; Roche; Sanofi
Speakers' Bureau - Bayer; Eisai; Kyowa Kirin; Merck Sharp & Dohme; Roche
 
Ana Belen Enguita
No Relationships to Disclose
 
Ramon Yarza
No Relationships to Disclose
 
Marisa Durán
No Relationships to Disclose
 
Justino Jiménez Almonacid
No Relationships to Disclose
 
Neus Baste
Consulting or Advisory Role - Amgen; Bayer; BioNTech; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; ISA Pharmaceuticals; Merck Serono; Merck Serono; MSD Oncology; Novartis; Roche; Roche
Research Funding - Merck Serono
 
Alberto Carral Maseda
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Merck Sharp & Dohme; Pierre Fabre; Sanofi; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Pierre Fabre; SERVIER
Research Funding - Bristol-Myers Squibb (Inst); G1 Therapeutics (Inst); Merck (Inst)
 
Marc Oliva
Honoraria - Merck; MSD Oncology; Transgene
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Merck; MSD Oncology
Other Relationship - Bristol-Myers Squibb; Merck; MSD Oncology
 
Pedro Perez Segura
Honoraria - BMSi; Merck; MSD Oncology
Consulting or Advisory Role - BMSi; Merck; MSD Oncology
Speakers' Bureau - BMSi; Merck; MSD Oncology
Research Funding - BMSi; Merck; MSD Oncology
Travel, Accommodations, Expenses - BMSi; Merck; MSD Oncology
 
Ana Medina-Colmenero
Honoraria - Bristol-Myers Squibb; Eisai; Eusa Pharma; Janssen-Cilag; Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen-Cilag
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Janssen-Cilag; PharmaMar; Roche; Sanofi
Other Relationship - AstraZeneca Spain; AstraZeneca Spain
 
Beatriz Cirauqui
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Virginia Arrazubi
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; Lilly
Travel, Accommodations, Expenses - Lilly; Merck; Sanofi
 
Vanesa Gutierrez Calderon
No Relationships to Disclose
 
Javier Martinez-Trufero
Consulting or Advisory Role - Eisai; PharmaMar
Research Funding - Blueprint Medicines (Inst); Lilly (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Merck; PharmaMar
 
Edel del Barco Morillo
No Relationships to Disclose
 
Almudena García Castaño
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Merck Sharp & Dohme
Speakers' Bureau - Bristol-Myers Squibb; Merck; Merck Sharp & Dohme
 
Jordi Rubió-Casadevall
Consulting or Advisory Role - Sanofi/Aventis
 
Laura Basterretxea
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Sanofi
 
Irene Brana
Consulting or Advisory Role - Achilles Therapeutics; Cancer Expert Now; eTheRNA Immunotherapies; Merck Sharp & Dohme; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); GlaxoSmithKline (Inst); Gliknik (Inst); Immutep (Inst); ISA Pharmaceuticals (Inst); Janssen Oncology (Inst); Kura Oncology (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Nanobiotix (Inst); Northern Biologics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Seagen (Inst); Shattuck Labs (Inst); VCN Biosciences (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Ricard Mesia
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Merck KGaA; MSD; Nanobiotix; Roche; Seagan
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb